Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03957 |
| Species: | Homo sapiens |
| Position : | chr17:45414208-45414987 |
| Year: | 2020 |
| Title: | BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | breast cancer |
| PMID: | 32352029 |
| MONDO: | MONDO:0007254 |
| Tissue: | breast |
| Tissue Ontology ID: | UBERON:0000310 |
| Cell Source: | 293T human CLDN18.2 |
| CVCL ID: | CVCL_UE18 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Functional perturbation assay; In vivo functional validation |
| High Throughput Method: | ChIP-exo, RNA-seq, RPPA; RNA-seq |
| Low Throughput Method: | ChIP-qPCR, shRNA Knockdown, RT-qPCR, Western blot, In vivo Invasion Assay; ChIP; In vivo phenotyping |
| Target gene : | ITGB3 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_03985 | chr17:45414208-45414987 | breast | mammary epithelial cell | NA |